Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Società Chimica Mugello, a subsidiary of Fresenius Kabi, is an Italian pharmaceutical manufacturing company specializing in sterile solutions and medical devices for infusion therapy. Located in Vicchio, the company operates as a key production hub for the development and large-scale manufacturing of intravenous solutions, clinical nutrition products, and flexible bags for pharmaceutical use. Their expertise lies in the formulation and filling of parenteral drugs, including electrolytes, glucose solutions, and specialized bags for dialysis and nutrition. As part of a global healthcare leader, the facility adheres to strict GMP standards to supply critical care products to international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Società Chimica Mugello.